Evidence map›Paper›PMID 36790304›Full record

ArticleArquivos brasileiros de cardiologia2023

Ten-Year Survival of Heart Failure Patients with Left Ventricular Ejection Fraction of 40-59%: A Potential Phenotypic Classification?

Luiz Claudio Danzmann, Luiz Carlos Bodanese, Aline Petracco Petzold, Anna Paula Tscheika, Ellen Hettwer Magedanz, Lucas Celia Petersen, Evgeny Belyavskiy, Fernanda Lourega Chieza

Abstract readLetter
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luiz Claudio DanzmannUniversidade Luterana do Brasil, Canoas, RS - Brasil.ORCID 0000-0002-5774-2780
Luiz Carlos BodaneseHospital São Lucas da PUCRS, Porto Alegre, RS - Brasil.
Aline Petracco PetzoldPontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS - Brasil.ORCID 0000-0003-0223-2713
Anna Paula TscheikaHospital São Lucas da PUCRS, Porto Alegre, RS - Brasil.
Ellen Hettwer MagedanzHospital São Lucas da PUCRS, Porto Alegre, RS - Brasil.
Lucas Celia PetersenHospital São Lucas da PUCRS, Porto Alegre, RS - Brasil.ORCID 0000-0002-3958-8521
Evgeny BelyavskiyCharité Universitätsmedizin Berlin, Berlin - Alemanha.ORCID 0000-0001-9940-0829
Fernanda Lourega ChiezaSanta Casa de Misericórdia de Porto Alegre, Porto Alegre, RS - Brasil.ORCID 0000-0002-2117-542X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Definitions of left ventricular ejection fraction (LVEF) cut-off values for HF with mildly reduced LVEF (HFmrEF) have been a subject of debate, in the face of evidence that some drugs used in the treatment of HF with LFEV < 40% (HFrEF) are also effective in patients with LVEF < 60%. The aim of this study was to compare overall survival and cardiovascular survival in HF patients with LVEF of 40-59% in patients with HFrEF and HF with LVEF ≥ 60%. Patients with decompensated HF who met the Framingham diagnostic criteria at hospital admission between 2009 and 2011 were included. Patients were divided into HFrEF, HF with LVEF 40-59%, and HF with LVEF ≥ 60%. The Kaplan-Meier was used to determine ten-year overall survival and cardiovascular survival. The statistical significance was established at p<0.05. A total of 400 patients were included, with a mean age of 69 ± 14 years. Cardiovascular survival in patients with HF and LVEF of 40-59% was not significantly different than in patients with HFrEF (adjusted Hazard Ratio [HR] 0.86; 95% Confidence Interval [CI] 0.61-1.22, Ptrend = NS), but was statistically different compared with patients with LVEF ≥ 60% (adjusted HR of 0.64; 95% CI 0.44-0.94, Ptrend = 0.023). No difference was found in 10-year survival between the LVEF groups. Patients with HF and LVEF ≥ 60% had significantly higher cardiovascular survival compared with the other groups.

Indexed as

Heart FailureVentricular Function, LeftAgedAged, 80 and overHospitalizationHumansMiddle AgedPrognosisStroke Volume

Identifiers

PMID36790304
PMCPMC10389085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.